Comparison

Heptaplatin European Partner

Item no. TMO-T21307-5mg
Manufacturer TargetMol
CASRN 146665-77-2
Amount 5 mg
Quantity options 100 mg 10 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles [Pt+6].[O--]C(=O)CC([O--])=O.CC(C)C1O[C@H](C[NH-])[C@@H](C[NH-])O1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias NSC644591 NSCD644591 SKI2053R,Heptaplatin Sunpla,HTP
Shipping Condition Cool pack
Available
Manufacturer - Targets
Others
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
471.36
Description
Heptaplatin, a new platinum derivative with anticancer activity, is used against various cancer cell lines, including cisplatin-resistant cancer cell lines. It has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in the treatment of advanced gastric cancer.
Pathways
Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close